Concepedia

Publication | Closed Access

Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse‐free survival

22

Citations

9

References

2010

Year

Abstract

Patients suffering from palmar hyperhidrosis have a longer lasting disease, and a length of disease more than 20 years in these patients influences the RFS after BTX-A treatment.

References

YearCitations

Page 1